UNSPSC 51422410: Fludrocortisone

This classification denotes a therapeutic glucocorticoid with the molecular formula C21H29FO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U0476M545B, chemically known as 9-fluoro-11beta,17,21-trihydroxypregn-4-ene-3,20-dione but generally known as fludrocortisone, which bears US NIH Compound Identifier 31378. European Medicines Agency schedules Fludrocortisone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07684MIG. The term FLUDROCORTISONE is an International Non-Proprietary Name.

UNSPSC 51422410 Fludrocortisone is a Commodity code for a specific corticosteroid pharmaceutical product, yet the recent state and local opportunities tagged under it do not involve fludrocortisone procurement. The code shows a significant mismatch between its nominal scope and what is actually being solicited: the two recent opportunities focus on naloxone and safe drug deactivation systems (Seminole County, Florida) and direct-to-manufacturer prescription fulfillment strategy (Texas Health and Human Services Commission), neither of which aligns with fludrocortisone as a pharmaceutical commodity. The code lacks relevant recent procurement activity grounded in its stated product scope.

Seminole County issued an Invitation for Bid (IFB 60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, while the Texas HHS Commission released a Request for Information (RFI HHS0017013) on April 3, 2026, to gather vendor capabilities around direct-to-manufacturer prescription programs rather than specific pharmaceutical commodities. Neither opportunity represents purchasing under the fludrocortisone code's intended scope. State and local procurement professionals evaluating this code should treat it as inactive for fludrocortisone-specific opportunities in the current market cycle.